Abstract
Traditionally, the diagnosis of neurological and neuromuscular disorders was based on patient history, clinical findings, and pedigree analysis. As the result of the Human Genome Project and advances in the fields of cytogenetics and molecular genetics, genes involved in both normal and pathologic processes have been mapped, cloned, and characterized. The types of DNA mutations that have been implicated in neurological diseases include trinucleotide repeat expansions, point mutations, insertions, deletions, and duplications. This chapter describes selected disorders that exemplify the types of mutations and molecular mechanisms involved in neurological and neuro-muscular disorders that have been identified to date.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fu, Y. H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkerk, A. H. M. H., Holden, J. J. A., Fenwick, R. G., Jr., Warren, S. T., Oostra, B. A., Nelson, D. L., and Caskey, C. T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047–1058, 1991.
La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77–79, 1991.
La Spada, A. R., Paulson, H. L., and Fischbeck, K. H. Trinucleotide repeat expansion in neurological disease. Ann. Neurol. 36:814–822, 1994.
Bates, G. and Lehrach, H. Trinucleotide repeat expansions and human genetic disease. BioEssays 16:277–284, 1994.
Plassart, E. and Fontaine, B. Genes with triplet repeats: a new class of mutations causing neurological diseases. Biomed. Pharmacother. 48:191–197, 1994.
Caskey, C. T., Pizzuti, A., Fu, Y. H., Fenwick, R. J., Jr., and Nelson, D. L. Triplet repeat mutations in human disease. Science 256:784–789, 1992.
Zuhlke, C., Riess, O., Bockel, B., Lange, H., and Thies, U. Mitotic stability and meiotic variability of the (CAG)„ repeat in the Huntington disease gene. Hum. Mol. Genet. 2:2063–2067, 1993.
Snow, K., Tester, D. J., Kruckeberg, K. E., Schaid, D. J., and Thibodeau, S. N. Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. Hum. Mol. Genet. 9:1543–1551, 1994.
Zoghbi, H. Y. and Orr, H. T. Spinocerebellar ataxia type 1. Semin. Cell Biol. 6:29–35, 1995.
Snow, K., Doud, L. K., Hagerman, R., Pergolizz, R. G., Erster, S. H., and Thibodeau, S. N. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the gen-eral population. Am. J. Hum. Genet. 53:1217–1228, 1993.
La Spada, A. R., Roling, D. B., Harding, A. E., Warner, C. L., Spiegel, R., Hausmanowa-Petrusewicz, I., Yee, W.-C., and Fischbeck, K. H. Meiotic stability and genotype-pheno-type correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet. 2:301–304, 1992.
Maciel, P., Gaspar, C., DeStefano, A. L., Silveira, I., Coutinho, P., Radvany, J., Dawson, D. M., Sudarsky, L., Guimaraes, J., Loureiro, J. E. L., Nezarati, M. M., Corwin, L. I., Lopes-Cendes, I., Rooke, K., Rosenberg, R., MacLeod, P., Farrer, L. A., Sequeiros, J., and Rouleau, G. A. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am. J. Hum. Genet. 57:54–61, 1995.
Nagafuchi, S., Yanagisawa, H., Sato, K., Shirayama, T., Ohsaki, E., Bundo, M., Takeda, T., Tadokoro, K., Kondo, I., Murayama, N., Tanaka, Y., Kikushima, H., Umino, K., Kurosawa, H., Furukawa, T., Nihei, K., Inoue, T., Sano, A., Komure, O., Takahashi, M., Yoshizawa, T., Kanazawa, I., and Yamada, M. Dentatorubral and pallidoluysian atro-phy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet. 6:14–18, 1994.
Tsilfidis, C., MaKenzie, A. E., Mettler, G., Barcelo, J., and Korneluk, R. G. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nature Genet. 1:192–195, 1992.
Orr, H. T., Chung, M., Banfi, S., Kwiatkowski, T. J., Jr., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., and Zoghbi, H. Y. Expansion of an unstable trinucteotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4:221–226, 1993.
Andrew, S. E., Goldberg, Y. P., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M. A., Graham, R. K., and Hayden, M. R. The rela-tionship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nature Genet. 4:398–403, 1993.
Chung, M., Ranum, L. P. W., Duvick, L. A., Servadio, A., Zoghbi, H. Y., and Orr, H. T. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type 1. Nature Genet. 5:254–258, 1993.
Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., Gray, J., Conneally, P., Young, A., Penney, J., Hollingsworth, Z., Shoulson, I., Lazzarini, A., Falek, A., Koroshetz, W., Sax, D., Bird, E., Vonsattel, J., Bonilla, E., Alvir, J., Bickham Conde, J., Cha, J.-H., Dure, L., Gomez, F., Ramos, M., Sanchez-Ramos, J., Snodgrass, S., de Young, M., Wexler, N., Moscowitz, C., Penchaszadeh, G., MacFarlane, H., Anderson, M., Jenkins, B., Srinidhi, J., Barnes, G., and MacDonald, M. Trinucleotide repeat length instability and age of onset in Huntington’s disease. Nature Genet. 4:387–392, 1993.
Reyniers, E., Vits, L., de Boulle, K., Van Roy, B., Van Velzen, D., de Graaf, E., Verkerk, A. J. M. H., Jorens, H. Z. J., Darby, J. K., Oostra, B., and Willems, P. J. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nature Genet. 4:143–146, 1993.
Fu, Y.-H., Pizzuti, A., Fenwick, R. G., Jr., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., Wieringa, B., Korneluk, R., Perryman, M. B., Epstein, H. F., and Caskey, C. T. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256–1258, 1992.
Hoogeveen, A., Willemsen, R., Meyer, N., Rooij, K. E., Roos, R. A. C., Ommen, Get-Jan, B. V., and Galjaard, H. Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2:2069–2073, 1993.
Li, X. J., Li, S. H., Sharp, A. H., Nucifora, F. C., Jr., Schilling, G., Lanahan, A., Worley, P., Snyder, S. H., and Ross, C. A. A huntington-associated protein enriched in brain with implication for pathology. Nature 378:398–402, 1995.
La Spada, A. R., Paulson, H. L., and Fischbeck, K. H. Trinucleotide repeat expansion in neurological disease. Ann. Neurol. 6:814–822, 1994.
Mhatre, A. N., Trifiro, M. A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G., and Pinsky, L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genet. 5:184–188, 1993.
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., and Nelson, D. L. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817–822, 1991.
Fu, Y. H., Friedman, D. L., Richards, S., Pearlman, J. A., Gibbs, R. A., Pizzuti, A., Ashizawa, T., Perryman, B., Scarlato, G., Fenwick, R. G., Jr., and Caskey, C. T. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260:235–238, 1993.
Sabouri, L. A., Mahadevan, M. S., Narang, M., Lee, D. S. C., Surh, L. C., and Korneluk, R. G. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nature Genet. 4:233–238, 1993.
Timchenko, L., Monckton, D. G., and Caskey, C. T. Myotonic dystrophy: an unstable CTG repeat in a protein kinase gene. Semin. Cell Biol. 6:13–19, 1995.
Waren, S. T. and Nelson, D. L. Advances in molecular analysis of fragile X syndrome. JAMA 7:536–542, 1994.
Taylor, A. K., Safanda, J. F., Fall, M. Z., Quince, C., Lang, K. A., Hull, C. E., Carpenter, I., Staley, L. W., and Hagerman, R. J. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 271:507–514, 1994.
Pearn, J. Spinal muscular atrophies, in Principles and Practice ofMedical Genetics, 2nd ed., vol. 1, Emery, A. and Rimoin, A., eds., Churchill Livingston, New York, pp. 565– 578, 1990.
Baraitson, M. The Genetics of Neurologic Disorders, 2nd ed., Oxford University Press, pp. 248–257, 1990.
Davies, K. E., Thomas, N. H., Daniels, R. J., and Dubowitz, V. Molecular studies of spi-nal muscular atrophy. Neuromuscular Disord. 1:83–85, 1991.
Melki, J., Lefebvre, S., Burglen, L., Burlet, P., Clermont, O., Millasseau, P., Reboullet, S., Benichou, B., Zeviani, M., Le Paslier, D., Cohen, D., Weissenbach, J., and Munnich, A. De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 264:1474–1477, 1994.
Lefebvre, S., Burglen„ Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., Le Paslier, D., Frezal, J., Cohen, D., Weissenbach, J., Munnich, A., and Melki, J. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155–165, 1995.
Roy, N., Mahadevan, M. S., McLean, M., Shutler, G., Yaraghi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X., Salih, M., Aubry, H., Tamai, K., Guan, X., Ioannou, P., Crawford, T. O., de Jong, P. J., Surh, L., Ikeda, J.-E., Komeluk, R. G., and MacKenzie, A. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167–178, 1995.
Hahnen, E., Forkert, R., Marke, C., Rudnikschoneborn, S., Shonling, J., Zerres, K., and Wirth, B. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy. Evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum. Mol. Genet. 4:1927–1933, 1995.
Rudnik-Schoneborn, S., Rohrig, D., Morgan, G., Wirth, B., and Zerres, K. Autosomal recessive proximal spinal muscular atrophy in 101 sibs out of 48 families: Clinical picture, influence of gender, and genetic implications. Am. J. Med. Genet. 51:70–76, 1994.
Cobben, J. M., van der Steege, G., Grootscholten, P., de Visser, M., Scheffer, H., and Buys, C. H. C. M. Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am. J. Hum. Genet. 57:805–808, 1995.
Wirth, B., Rudnik-Schoneborn, S., Hahnen, E., Rohrig, D., and Zerres, K. Prenatal predic-tion in families with autosomal recessive proximal spinal muscular atrophy (5q11.2-q13.3): molecular menetics and clinical experience in 109 cases. Prenat. Diagn. 15:407–417, 1995.
Wang, C. H., Xu, J., Carter, T. A., Ross, B. M., Sugarman, E. A., Allitto, B. A., Penchaszadeh, G. K., Munsat, T. L., and Gilliam, T. C. Analysis of the survival motor neuron (SMN) gene in spinal muscular atrophy families. Am. Soc. Hum. Genet. 57:A253, 1995.
Gutman, D. H. and Collins, F. von Recklinghausen Neurofibromatosis, in The Metabolic and Molecular Bases of Inherited Disease, 7th ed., Scriver C., ed., McGraw-Hill, New York, pp. 677–692, 1995.
Barker, D., Wright, E., Nguyen, K., Cannon, L., Fain, P., Goldgar, D., Bishop, D. T., Carey, J., Baty, B., Kivlin, J., Willard, H., Wayne, J. S., Greig, G., Leinwand, L., Nakamura, Y., O’Connell, P., Leppert, M., Lalouel, J.-M., White, R., and Skolnick, M. Gene for von Recklinghausen neurofibromatosis is in the perimcentromeric region of chro-mosome 17. Science 236:1100–1102, 1987.
Viskochil, D., White, R., and Cawthon, R. The neurofibromatosis type 1 gene. Ann. Rev. Neurosci. 16:183–205, 1993.
Upadhyaya, M., Shaw, D. J., and Harper, P. S. Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and polymorphisms in the NF1 gene. Hum. Mutat. 4:83– 101, 1994.
Johnson, M. R., DeClue, J. E., Felzmann, S., Vass, W. C., Xu, G., White, R., and Lowy, D. R. Neurofibromin can inhibit ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol. Cell. Biol. 14:641–645, 1994.
McCormick, F. Ras signaling and NFl. Curr. Opinion Gene. Devel. 5:51–55, 1995.
Ishioka, C., Ballester, R., Engelstein, M., Vidal, M., Kassel, J., The, I., Bernards, A., Gusella, J. F., and Friend, S. H. A functional assay for heterozygous mutations in GTPase activation protein related domain of the neurofibromin type 1 gene. Oncogene 10:841–847, 1995.
Heim, R. A., Kam-Morgan, L. M. W., Binnie, C. G., Corna, D. D., Cayouette, M. C., Farber, R. A., Aylsworth, A. S., Silverman, L. M., and Luce, M. C. Neurofibromatosis 1 (NF 1) truncating mutations are dispersed throughout the NF 1 gene (abstract). Am. J. Hum. Gen. 57(Suppl.):A214, 1995.
Boder, E. Ataxia-telangiectasia: an overview. Kroc Foundation Series 19:1–63, 1985.
Blaese, R. M. Genetic immunodeficiency syndromes with defects in both T- and B-lym-phocyte function, in The Metabolic and Molecular Bases of Inherited Disease, 7th ed., Scriver, C., ed., McGraw-Hill, New York, pp. 3901,3902, 1995.
Waldmann, T. A., Strober, W., and Blaese, R. M. Immunodeficiency disease and malig-nancy. Ann. Intern. Med. 77:605,1972.
Spector, B. D., Perry, G. S., and Kersey, J. H. Genetically determined immunodeficiency disease and malignancy: report from the immunodeficiency-cancer registry. Clin. Immunol. Immunopathol. 11:12, 1978.
Gatti, R. A. Ataxia-telangiectasia. Dermatol. Clin. 13:1–6, 1995.
West, C. M., Elyan, S. A., Berry, P., Cowan, R., and Scott, D. A comparison of the radi-osensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia, and ataxia-telangiectasia heterozygotes. J. Radiat. Biol. 68:197–203, 1995.
Swift, M., Morrell, D., Massey, R. B., and Chase, C. L. Incidence of cancer in 161 fami-lies affected by ataxia-telangiectasia. New Engl. J. Med. 325:1831–1836, 1991.
Easton, D. F. Cancer risks in ataxia-telangiectasia heterozygotes. J. Radiat. Biol. 66(Suppl. 6):S177–182, 1994.
Kojis, T. L., Schneck, R. R., Gatti, R. A., and Sparkes, R. S. Tissue specificity of chromo-somal rearrangements in ataxia-telangiectasia. Hum. Genet. 83:347–52, 1989.
Kaufman, W. K. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer Metastasis Rev. 14:31–41, 1995.
Jaspers, N. G., Gatti, R. A., Baan, C., Linssen, P. C., and Bootsma, D. Genetic comple-mentation analysis of ataxia-telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet. Cell Genet. 49:259–263, 1988.
Gatti, R. A., Berkel, I., Boder, E., Braedt, G., Charmley, P., Concannon, P., Ersoy, F., Foround, T., Jaspers, N. G. J., Lange, K., Lathrop, G. M., Leppert, M., Nakamura, Y., O’Connell, P., Paterson, M., Salser, W., Sanal, O., Silver, J., Sparkes, R. S., Susi, E., Weeks, D. E., Wei, S., White, R., and Yoder, F. Localization of an ataxia-telangiectasia gene to chromosome 11q22–23. Nature 336:577–580, 1988.
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Malcolm, A., Raylor, R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., and Shiloh, Y. A single ataxia telangiectasia gene with a prod-uct similar to PI-3 Kinase. Science 268:1749–1753, 1995.
Charcot, J. M., Marie, P. Sur une forme particuliere d’atrophie musculaire progressive solvent familiale debutante par les pieds et les jambes et atteigrante plus tard les mains. Rev. Med. 6:97, 1886.
Tooth, H. H. The Peroneal Type ofProgressive Muscular Atrophy. H. K. Lewis, London, 1886.
Wise, C. A., Garcia, C. A., Davis, S. N., Zhang, H., Pentao, L., Patel, P. I., and Lupski, J. R. Molecular analysis of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am. J. Hum. Genet. 53:853, 1993.
Chance, P. F., Abbas, N., Lensch, M. W., Pentao, L., Roa, B. B., Patel, P. L., and Lupski, J. R. Two autosomal dominant neuropathies results from reciprocal DNA duplication/ deletion of a region on chromosome 17. Hum. Mol. Genet. 3:223–228, 1994.
Lupski, J. R., Montes de Oca-Luna, R., Slaugenhaupt, S., Pentao, L., Guzzetta, V., Trask, B. J., Saucedo-Cardenas, O., Barker, D. F., Killan, J. M., Garcia, C. A., Chakravarti, A., and Patel, P. I. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219, 1991.
Matsunami, N., Smith, B., Ballard, L., Lensch, M. W., Robertson, M., Albertsen, H., Hanemann, C. O., Muller, H. W., Bird, T. D., White, R., and Chance, P. F. Peripheral myelin protein-22 gene maps in the duplication of chromosome 17p 11.2 associated with Charcot-Marie-Tooth 1A. Nature Genet. 1:176, 1992.
Nicholson, G. A., Valentijn, L. J., Cherryson, A. K., Kennerson, M. L., Bragg, T. L., DeKroon, R. M., Ross, D. A., Pollard, J. D., Mcleod, J. G., Bolhius, P. A., and Baas, F. A frame shift mutation in the PMP22 gene in hereditary peripheral neuropathy with liability to pressure palsies. Nature Genet. 6:263–266, 1994.
Wright, E. C., Goldgar, D. E., Fain, P. R., Barker, D. F., and Skolnick, M. H. A genetic map of human chromosome 17p. Genomics 7:103–109, 1990.
Ballabio, A. and Zoghbi, H. Y. Charcot-Marie-Tooth Disease and hereditary neuropathy with liability to pressure palsies, in The Metabolic and Molecular Basis of Inherited Disease, 7th ed., McGraw-Hill, New York, pp. 4569–4573, 1995.
Chance, P. F., Alderson, M. K., Leppig, K. A., Lensch, M. W., Matsunami, N., Smith, B., Swanson, P. D., Odelberg, S. J., Disteche, C. M., and Bird, T. D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143, 1993.
Windebank, A. J., Schenone, A., and Dewald, G.W. Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy-two genetically distinct dis-orders. Mayo Clin. Proc. 70:743–746, 1995.
Roa, B. B., Garcia, C. A., Suter, U., Kulpa, D. A., Wise, C. A., Mueller, J., Welcher, A. A., Snipes, G. J., Shooter, E. M., Patel, P. I., and Lupski, J. R. Charcot-Marie-Tooth dis-ease type lA association with a spontaneous point mutation in the PMP22 gene. New Engl. J. Med. 329:96, 1993.
Emery, A. E. H. Clinical features, in Duchenne Muscular Dystrophy, 2nd ed., Motulsky, A. G., Harper, P. S., Bobrow, M., and Scriver, C., eds. Oxford University Press, New York, pp. 26–41, 1993.
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Muller, C. R., Lindlof, M., and Kaariainen, H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45:498, 1989.
Monaco, A. P. and Kunkel, L. M. Cloning of the Duchenne/Becker muscular dystrophy locus. Adv. Hum. Genet. 17:61, 1988.
Ervasti, J. M. and Campbell, K. P. Membrane organization of the dystrophin-glyco-membrane complex. Cell 66:1121, 1991.
Gorecki, D. C., Monaco, A. P., Derry, J. M. J., Walker, A. P., Barnard, E. A., and Barnard, P. J. Expression of four alternative transcripts in brain regions regulated by different promotors. Hum. Mol. Genet. 1:505, 1992.
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., and Kunkel, L. M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and prelimi-nary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509, 1987.
Coffey, A. J., Roberts, R. G., Green, E. D., Cole, C. G., Butler, R., Anand, R., Giannelli, F., and Bentley, D. R. Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. Genomics 12:474, 1992.
Worton, R. G. and Brooke, M. H. The X-linked muscular dystrophies, in The Metabolic and Molecular Basis ofInherited Disease, 7th ed., McGraw-Hill, New York, pp. 4195– 4226, 1995.
Roberts, R. G., Coffey, A. J., Bobrow, M., Bentley, D. R. Exon structure of the human dystrophin gene. Genomics 16:536, 1993.
Chamberlain, J. S., Gibbs, R. A., Ranier, J. E., Nguyen, P. N., and Caskey, C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 16:11141, 1988.
Beggs, A. H., Koenig, M., Boyce, F. M., and Kunkel, L. M. Detection of 98% of DMD/ BMD gene deletions by polymerase chain reaction. Hum. Genet. 86:45, 1990.
Clements, P. R., Fenwick, R. G., Chamberlain, J. S., Gibbs, R. A., de Andrade, M., Chakroborty, R., and Caskey, C. T. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am. J. Hum. Genet. 49:951–960, 1991.
Beggs, A. H. and Kunkel, L. M. Improved diagnosis of Duchenne/Becker Muscular Dys-trophy. J. Clin. Invest. 85:613–619, 1990.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wick, M.J., Crifasi, P.A., Wang, Z., Thibodeau, S.N. (1997). Genetic Basis of Neurologic and Neuromuscular Diseases. In: Coleman, W.B., Tsongalis, G.J. (eds) Molecular Diagnostics. Pathology and Laboratory Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2588-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2588-9_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-2590-2
Online ISBN: 978-1-4757-2588-9
eBook Packages: Springer Book Archive